Private equity deals in pharmaceutical in Canada remained flat in Q3 2024
In the Canadian pharmaceutical industry, there were two private equity deals announced in Q3 2024, worth a total value of…
In the Canadian pharmaceutical industry, there were two private equity deals announced in Q3 2024, worth a total value of…
Analysis of the key themes driving private equity deal activity reveals that artificial intelligence accounted for three pharmaceutical deals announced…
Analysis of the key themes driving M&A activity reveals that ecommerce accounted for eight pharmaceutical deals announced in Q3 2024,…
Analysis of the key themes driving private equity deal activity reveals that COVID-19 accounted for two pharmaceutical deals announced in…
The Cyclin Dependent Kinase 4 pipeline drugs market research report outlays comprehensive information on the Cyclin Dependent Kinase 4 targeted…
Lyell Immunopharma. has been granted a patent for EGFR-derived polypeptides that enhance the cell surface expression of truncated EGFR markers.…
Telesis Bio. has been granted a patent for a method of synthesizing DNA molecules with specific sequences. The process involves…
Laurus Labs has been granted a patent for an improved process to prepare dapagliflozin, a sodium-dependent glucose transporter inhibitor used…
Agile Therapeutics. has been granted a patent for a transdermal drug delivery device designed to minimize skin irritation and detachment…
Vivos Therapeutics. has been granted a patent for an innovative oral appliance designed to promote jaw development and alleviate sleep…